Furthermore, in soft tissue sarcoma patients, high CCL2 mRNA expression is associated with a good prognosis [36], and higher CCL2 expression was significantly associated with better OS in non-small-cell lung cancer (NSCLC) patients [37]. The gene discussed is CCL2; the disease is non-small cell lung carcinoma.